SCHEMBL24628004

SCHEMBL24628004

CCCCCCCCC(CCCCCCCC)OC(=O)CCN(CCC(=O)OC(CCCCCCCC)CCCCCCCC)CCN1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
THRB P10828 4/20 0.40
THRA P10827 2/20 0.40
LMNA P02545 5/20 0.40
KDM4E B2RXH2 1/20 0.38
BCHE P06276 2/20 0.38
CYP1A2 P05177 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
ADRA2C P18825 1/20 0.38
DRD4 P21917 1/20 0.38
ACHE P22303 1/20 0.38
SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627850 0.99 GAA (0.45) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL24628012 0.93 GAA (0.45) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL17367570 0.93 GAA (0.47) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL31663675 0.92 MAPK1 (0.43) GAAMAPTMAPK1ALDH1A1LMNA
SCHEMBL24627862 0.91 GAA (0.43) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL24627701 0.90 MAPT (0.41) GAAMAPTMAPK1ALDH1A1THRB
SCHEMBL31420403 0.89 GAA (0.49) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL31663671 0.88 MAPK1 (0.46) GAAMAPTMAPK1ALDH1A1LMNA
SCHEMBL24627697 0.88 GAA (0.47) GAAMAPTMAPK1ALDH1A1L3MBTL1
SCHEMBL31420404 0.88 GAA (0.47) GAAMAPTMAPK1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF NPC1L1, PLA2G4A, PLA2G2A GAA 975/4885MAPT 2748/4885MAPK1 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.